XIANG; Rong

Patent Applications and Registrations

Patent applications and USPTO patent grants for XIANG; Rong.The latest application filed is for "single-walled carbon nanotube and structure having layer laminated on said single-walled carbon nanotube, and method for producing same".

Company Profile

5.20.21

XIANG; Rong - Tokyo JP
Xiang; Rong - Beijing CN
Xiang; Rong - San Diego CA
Xiang; Rong - Nanjing CN
Xiang; Rong - Guangzhou CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Single-walled Carbon Nanotube And Structure Having Layer Laminated On Said Single-walled Carbon Nanotube, And Method For Producing Same App 20200399128 - MARUYAMA; Shigeo ; et al.	2020-12-24
Scenario based logging Grant 10,552,812 - Fan , et al. Fe	2020-02-04
Scenario based logging Grant 10,546,279 - Fan , et al. Ja	2020-01-28
Nanoparticle-based tumor-targeted drug delivery Grant 10,335,420 - Reisfeld , et al.	2019-07-02
Microbe transformant for weight loss and lipid reduction, the method for constructing the transformant, and application thereof Grant 10,113,184 - Lin , et al. October 30, 2	2018-10-30
Method for producing two-dimensionally patterned carbon nanotube and two-dimensionally patterned carbon nanotube Grant 9,944,527 - Maruyama , et al. April 17, 2	2018-04-17
Scenario Based Logging App 20180101307 - Fan; Si Bin ; et al.	2018-04-12
The Micrbe Transformant For Weight Loss And Lipid Reduction, The Method For Constructing The Transformant, And Application Thereof App 20180051303 - LIN; Yan ; et al.	2018-02-22
Scenario Based Logging App 20170371552 - Fan; Si Bin ; et al.	2017-12-28
Nanoparticle-based Tumor-targeted Drug Delivery App 20170224838 - REISFELD; Ralph A. ; et al.	2017-08-10
DNA vaccines against tumor growth and methods of use thereof Grant 9,655,815 - Xiang , et al. May 23, 2	2017-05-23
Nanoparticle-based tumor-targeted drug delivery Grant 9,629,922 - Reisfeld , et al. April 25, 2	2017-04-25
Nanoparticle-based tumor-targeted drug delivery Grant 9,616,137 - Reisfeld , et al. April 11, 2	2017-04-11
Message transmission for distributed computing systems Grant 9,509,641 - Li , et al. November 29, 2	2016-11-29
Method For Producing Two-dimensionally Patterned Carbon Nanotube And Two-dimensionally Patterned Carbon Nanotube App 20160176712 - Maruyama; Shigeo ; et al.	2016-06-23
Dna Composition For Eliciting An Immune Response Against Tumor-associated Macrophages App 20150175996 - Reisfeld; Ralph A. ; et al.	2015-06-25
Dna Vaccines Against Tumor Growth And Methods Of Use Thereof App 20140322249 - Xiang; Rong ; et al.	2014-10-30
DNA vaccines against tumor growth and methods of use thereof Grant 8,716,254 - Xiang , et al. May 6, 2	2014-05-06
Nanoparticle-based Tumor-targeted Drug Delivery App 20130330399 - Reisfeld; Ralph A. ; et al.	2013-12-12
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof Grant 8,241,637 - Reisfeld , et al. August 14, 2	2012-08-14
Nanoparticle-based Tumor-targeted Drug Delivery App 20120058177 - Reisfeld; Ralph A. ; et al.	2012-03-08
Dna Composition Encoding An Immunogenic Vegf Receptor Peptide And Methods Of Use Thereof App 20120039931 - REISFELD; Ralph A. ; et al.	2012-02-16
Method For Producing Two-dimensionally Patterned Carbon Nanotube And Two-dimensionally Patterned Carbon Nanotube App 20110311763 - Maruyama; Shigeo ; et al.	2011-12-22
DNA vaccines against tumor growth and methods of use thereof Grant 8,053,421 - Luo , et al. November 8, 2	2011-11-08
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof Grant 8,048,428 - Reisfeld , et al. November 1, 2	2011-11-01
DNA vaccines against tumor growth and methods of use thereof App 20100136058 - Luo; Yunping ; et al.	2010-06-03
Dna Composition For Eliciting An Immune Response Against Tumor-associated Macrophages App 20090275642 - Reisfeld; Ralph A. ; et al.	2009-11-05
DNA vaccines against tumor growth and methods of use therof Grant 7,569,552 - Luo , et al. August 4, 2	2009-08-04
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof Grant 7,279,464 - Xiang , et al. October 9, 2	2007-10-09
Dna vaccines against tumor growth and methods of use thereof App 20070110717 - Luo; Yunping ; et al.	2007-05-17
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof App 20070059323 - Reisfeld; Ralph A. ; et al.	2007-03-15
DNA vaccine against proliferating endothelial cells and methods of use thereof Grant 7,094,410 - Reisfeld , et al. August 22, 2	2006-08-22
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof App 20050287123 - Xiang, Rong ; et al.	2005-12-29
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof Grant 6,923,958 - Xiang , et al. August 2, 2	2005-08-02
DNA vaccines against tumor growth and methods of use thereof App 20040192631 - Xiang, Rong ; et al.	2004-09-30
DNA vaccine against proliferating endothelial cells and methods of use thereof App 20030185802 - Reisfeld, Ralph A. ; et al.	2003-10-02
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof App 20030176377 - Xiang, Rong ; et al.	2003-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.